151 related articles for article (PubMed ID: 9547001)
21. Laminin affects polymerization, depolymerization and neurotoxicity of Abeta peptide.
Morgan C; Bugueño MP; Garrido J; Inestrosa NC
Peptides; 2002 Jul; 23(7):1229-40. PubMed ID: 12128080
[TBL] [Abstract][Full Text] [Related]
22. Phage display and kinetic selection of antibodies that specifically inhibit amyloid self-replication.
Munke A; Persson J; Weiffert T; De Genst E; Meisl G; Arosio P; Carnerup A; Dobson CM; Vendruscolo M; Knowles TPJ; Linse S
Proc Natl Acad Sci U S A; 2017 Jun; 114(25):6444-6449. PubMed ID: 28584111
[TBL] [Abstract][Full Text] [Related]
23. Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation.
Abelein A; Gräslund A; Danielsson J
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5407-12. PubMed ID: 25825723
[TBL] [Abstract][Full Text] [Related]
24. AlphaB-crystallin, a small heat-shock protein, prevents the amyloid fibril growth of an amyloid beta-peptide and beta2-microglobulin.
Raman B; Ban T; Sakai M; Pasta SY; Ramakrishna T; Naiki H; Goto Y; Rao ChM
Biochem J; 2005 Dec; 392(Pt 3):573-81. PubMed ID: 16053447
[TBL] [Abstract][Full Text] [Related]
25. Can a bacterial endotoxin be a key factor in the kinetics of amyloid fibril formation?
Asti A; Gioglio L
J Alzheimers Dis; 2014; 39(1):169-79. PubMed ID: 24150108
[TBL] [Abstract][Full Text] [Related]
26. Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease.
Jean L; Thomas B; Tahiri-Alaoui A; Shaw M; Vaux DJ
PLoS One; 2007 Jul; 2(7):e652. PubMed ID: 17653279
[TBL] [Abstract][Full Text] [Related]
27. An Aβ42 variant that inhibits intra- and extracellular amyloid aggregation and enhances cell viability.
Oren O; Banerjee V; Taube R; Papo N
Biochem J; 2018 Oct; 475(19):3087-3103. PubMed ID: 30213841
[TBL] [Abstract][Full Text] [Related]
28. Inhibiting and reversing amyloid-β peptide (1-40) fibril formation with gramicidin S and engineered analogues.
Luo J; Otero JM; Yu CH; Wärmländer SK; Gräslund A; Overhand M; Abrahams JP
Chemistry; 2013 Dec; 19(51):17338-48. PubMed ID: 24218178
[TBL] [Abstract][Full Text] [Related]
29. Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy.
Soto C; Sigurdsson EM; Morelli L; Kumar RA; Castaño EM; Frangione B
Nat Med; 1998 Jul; 4(7):822-6. PubMed ID: 9662374
[TBL] [Abstract][Full Text] [Related]
30. Interactions of laminin with the amyloid beta peptide. Implications for Alzheimer's disease.
Morgan C; Inestrosa NC
Braz J Med Biol Res; 2001 May; 34(5):597-601. PubMed ID: 11323745
[TBL] [Abstract][Full Text] [Related]
31. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
[TBL] [Abstract][Full Text] [Related]
32. Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein.
Harper JD; Lieber CM; Lansbury PT
Chem Biol; 1997 Dec; 4(12):951-9. PubMed ID: 9427660
[TBL] [Abstract][Full Text] [Related]
33. Critical role of interfaces and agitation on the nucleation of Abeta amyloid fibrils at low concentrations of Abeta monomers.
Morinaga A; Hasegawa K; Nomura R; Ookoshi T; Ozawa D; Goto Y; Yamada M; Naiki H
Biochim Biophys Acta; 2010 Apr; 1804(4):986-95. PubMed ID: 20100601
[TBL] [Abstract][Full Text] [Related]
34. Understanding Amyloid-β Oligomerization at the Molecular Level: The Role of the Fibril Surface.
Barz B; Strodel B
Chemistry; 2016 Jun; 22(26):8768-72. PubMed ID: 27135646
[TBL] [Abstract][Full Text] [Related]
35. The C-terminus of the beta protein is critical in amyloidogenesis.
Jarrett JT; Berger EP; Lansbury PT
Ann N Y Acad Sci; 1993 Sep; 695():144-8. PubMed ID: 8239273
[TBL] [Abstract][Full Text] [Related]
36. Neurotoxicity of acetylcholinesterase amyloid beta-peptide aggregates is dependent on the type of Abeta peptide and the AChE concentration present in the complexes.
Muñoz FJ; Inestrosa NC
FEBS Lett; 1999 May; 450(3):205-9. PubMed ID: 10359075
[TBL] [Abstract][Full Text] [Related]
37. Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth.
McLaurin J; Franklin T; Zhang X; Deng J; Fraser PE
Eur J Biochem; 1999 Dec; 266(3):1101-10. PubMed ID: 10583407
[TBL] [Abstract][Full Text] [Related]
38. Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators.
Tõugu V; Karafin A; Zovo K; Chung RS; Howells C; West AK; Palumaa P
J Neurochem; 2009 Sep; 110(6):1784-95. PubMed ID: 19619132
[TBL] [Abstract][Full Text] [Related]
39. Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly.
De Lorenzi E; Chiari M; Colombo R; Cretich M; Sola L; Vanna R; Gagni P; Bisceglia F; Morasso C; Lin JS; Lee M; McGeer PL; Barron AE
J Alzheimers Dis; 2017; 59(4):1213-1226. PubMed ID: 28731438
[TBL] [Abstract][Full Text] [Related]
40. Solid-state NMR as a method to reveal structure and membrane-interaction of amyloidogenic proteins and peptides.
Naito A; Kawamura I
Biochim Biophys Acta; 2007 Aug; 1768(8):1900-12. PubMed ID: 17524351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
